Clinical trial
Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
NCT01265173 is registered in ClinicalTrials.gov with Korea University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis
- Lead sponsor
- Korea University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- June 30, 2018
- Enrollment
- 261 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
liver cirrhosis, sbp